Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ3510LO1M
Performance in the last:
Follow this Portfolio
1D 0.1 %
1W 4.3 %
2W 0.4 %
1M 0.4 %
3M -2.4 %
6M -3.7 %
9M 1.5 %
1Y 2.9 %
Alpha
-13.9%
Beta
0.75
sharpe-R
0.26
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
2.16
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2024-09-18 07:49:41
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -16.99%
Max. DrawDown Benchmark -8.41%

This Long Only strategy aims to find promising assets to invest in for a maximum holding period of 1 Month in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 10.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
3
Difficulty Level
2

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

Asset Asset Class Action Weight PnL
AGEN Agenus Inc. Equity Buy 10.94% 13.89%
AADI Aadi Bioscience, Inc. Equity Buy 10.08% 5.14%
PODD Insulet Corporation Equity Buy 11.97% 15.22%
ESPR Esperion Therapeutics, Inc. Equity Buy 8.89% -2.73%
NVCR NovoCure Limited Equity Buy 8.84% -0.17%
MYGN Myriad Genetics, Inc. Equity Buy 8.9% 6.04%
The percentage of cash held in the portfolio is: 40.38%
** The description of each asset is available Here

The latest 5 Compositions change

2024-09-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
AGEN Agenus Inc. Buy 10.73% 11.15%
AADI Aadi Bioscience, Inc. Buy 10.35% 7.43%
PODD Insulet Corporation Buy 11.95% 14.42%
ESPR Esperion Therapeutics, Inc. Buy 8.83% -3.83%
NVCR NovoCure Limited Buy 8.86% -0.5%
MYGN Myriad Genetics, Inc. Buy 8.72% 3.45%
The percentage of cash held in the portfolio is: 40.57%
New Assets Added
None
Assets Removed
Asset Action Perf %
APLS Sell All -8.89%
TVTX Sell All 48.65%
Assets Rebalanced
None
2024-09-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 9.85% -1.69%
AGEN Agenus Inc. Buy 10% -0.18%
AADI Aadi Bioscience, Inc. Buy 10.17% 1.71%
PODD Insulet Corporation Buy 12% 10.8%
TVTX Travere Therapeutics, Inc. Buy 12.74% 33.75%
ESPR Esperion Therapeutics, Inc. Buy 9.01% -5.46%
NVCR NovoCure Limited Buy 8.65% -6.37%
MYGN Myriad Genetics, Inc. Buy 8.77% 0.26%
The percentage of cash held in the portfolio is: 18.81%
New Assets Added
None
Assets Removed
Asset Action Perf %
CARA Sell All -18.08%
Assets Rebalanced
None
2024-09-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.04% 0.21%
CARA Cara Therapeutics, Inc. Buy 9.06% -9.62%
AGEN Agenus Inc. Buy 9.4% -6.22%
AADI Aadi Bioscience, Inc. Buy 10.34% 3.43%
PODD Insulet Corporation Buy 11.62% 7.2%
TVTX Travere Therapeutics, Inc. Buy 12.77% 33.96%
ESPR Esperion Therapeutics, Inc. Buy 8.85% -7.1%
NVCR NovoCure Limited Buy 8.5% -7.98%
MYGN Myriad Genetics, Inc. Buy 8.81% 0.63%
The percentage of cash held in the portfolio is: 10.61%
New Assets Added
None
Assets Removed
Asset Action Perf %
ALDX Sell All -6.49%
Assets Rebalanced
None
2024-09-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.48% 3%
CARA Cara Therapeutics, Inc. Buy 9.56% -6.12%
AGEN Agenus Inc. Buy 9.21% -9.51%
AADI Aadi Bioscience, Inc. Buy 10.62% 4.57%
PODD Insulet Corporation Buy 11.56% 5.05%
TVTX Travere Therapeutics, Inc. Buy 11.07% 14.37%
ESPR Esperion Therapeutics, Inc. Buy 8.73% -9.84%
ALDX Aldeyra Therapeutics, Inc. Buy 9.1% -3.01%
NVCR NovoCure Limited Buy 8.78% -6.48%
MYGN Myriad Genetics, Inc. Buy 8.89% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MYGN
Assets Removed
Asset Action Perf %
ORGO Sell All -12.72%
Assets Rebalanced
None
2024-09-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10% -1.42%
ORGO Organogenesis Holdings Inc. Buy 9.46% -6.71%
CARA Cara Therapeutics, Inc. Buy 9.5% -6.41%
AGEN Agenus Inc. Buy 9.27% -8.59%
AADI Aadi Bioscience, Inc. Buy 10.41% 2.86%
PODD Insulet Corporation Buy 11.6% 5.72%
TVTX Travere Therapeutics, Inc. Buy 9.98% 3.44%
ESPR Esperion Therapeutics, Inc. Buy 9.07% -6.01%
ALDX Aldeyra Therapeutics, Inc. Buy 9.35% 0%
NVCR NovoCure Limited Buy 9.35% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NVCR
Assets Removed
None
Assets Rebalanced
None
2024-09-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 9.61% -5.21%
ORGO Organogenesis Holdings Inc. Buy 9.67% -4.59%
CARA Cara Therapeutics, Inc. Buy 9.52% -6.12%
AGEN Agenus Inc. Buy 8.99% -11.33%
AADI Aadi Bioscience, Inc. Buy 10.41% 2.86%
PODD Insulet Corporation Buy 11.4% 3.96%
TVTX Travere Therapeutics, Inc. Buy 10.1% 4.69%
ESPR Esperion Therapeutics, Inc. Buy 9.59% -0.55%
ALDX Aldeyra Therapeutics, Inc. Buy 9.35% 0%
The percentage of cash held in the portfolio is: 11.35%
New Assets Added
  • ALDX
Assets Removed
Asset Action Perf %
CERS Sell All -11.34%
EGRX Sell All -11.35%
Assets Rebalanced
None
2024-09-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 9.85% -2.65%
ORGO Organogenesis Holdings Inc. Buy 9.76% -3.53%
CARA Cara Therapeutics, Inc. Buy 9.77% -3.5%
AGEN Agenus Inc. Buy 9.16% -9.51%
CERS Cerus Corporation Buy 9.29% -7.98%
AADI Aadi Bioscience, Inc. Buy 10.04% -0.57%
PODD Insulet Corporation Buy 11.07% 1.11%
EGRX Eagle Pharmaceuticals, Inc. Buy 9.81% -10.38%
TVTX Travere Therapeutics, Inc. Buy 9.62% 0%
ESPR Esperion Therapeutics, Inc. Buy 9.62% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • TVTX
  • ESPR
Assets Removed
Asset Action Perf %
ARDX Sell All -11.62%
NEOG Sell All -6.34%
Assets Rebalanced
None
2024-08-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.42% -3.45%
APLS Apellis Pharmaceuticals, Inc. Buy 9.34% -4.2%
ORGO Organogenesis Holdings Inc. Buy 10.1% 3.53%
CARA Cara Therapeutics, Inc. Buy 10.13% 3.79%
AGEN Agenus Inc. Buy 9.11% -6.58%
CERS Cerus Corporation Buy 9.16% -5.88%
AADI Aadi Bioscience, Inc. Buy 9.35% -4%
NEOG Neogen Corporation Buy 10.3% -2.15%
PODD Insulet Corporation Buy 10.55% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 10.55% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • PODD
  • EGRX
Assets Removed
None
Assets Rebalanced
None
2024-08-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.33% -2.35%
APLS Apellis Pharmaceuticals, Inc. Buy 9.49% -0.64%
ORGO Organogenesis Holdings Inc. Buy 9.93% 3.89%
CARA Cara Therapeutics, Inc. Buy 10.01% 4.66%
AGEN Agenus Inc. Buy 9.84% 2.93%
CERS Cerus Corporation Buy 9.3% -2.52%
AADI Aadi Bioscience, Inc. Buy 9.16% -4%
NEOG Neogen Corporation Buy 10.32% 0%
The percentage of cash held in the portfolio is: 22.63%
New Assets Added
  • NEOG
Assets Removed
Asset Action Perf %
CYH Sell All 4.72%
Assets Rebalanced
None
2024-08-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 11.75% 6.09%
ARDX Ardelyx, Inc. Buy 9.28% -0.94%
APLS Apellis Pharmaceuticals, Inc. Buy 9.36% -0.05%
ORGO Organogenesis Holdings Inc. Buy 10.03% 7.07%
CARA Cara Therapeutics, Inc. Buy 10.11% 7.87%
AGEN Agenus Inc. Buy 10.06% 7.31%
CERS Cerus Corporation Buy 9.35% 0%
AADI Aadi Bioscience, Inc. Buy 9.35% 0%
The percentage of cash held in the portfolio is: 20.7%
New Assets Added
  • CERS
  • AADI
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 11.05% -4.32%
ARDX Ardelyx, Inc. Buy 9.27% -5.02%
APLS Apellis Pharmaceuticals, Inc. Buy 9.59% -1.79%
ORGO Organogenesis Holdings Inc. Buy 9.49% -2.83%
CARA Cara Therapeutics, Inc. Buy 9.77% 0%
AGEN Agenus Inc. Buy 9.77% 0%
The percentage of cash held in the portfolio is: 41.07%
New Assets Added
  • CARA
  • AGEN
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 11.08% -2.95%
ARDX Ardelyx, Inc. Buy 9.66% 0%
APLS Apellis Pharmaceuticals, Inc. Buy 9.66% 0%
ORGO Organogenesis Holdings Inc. Buy 9.66% 0%
The percentage of cash held in the portfolio is: 59.94%
New Assets Added
  • ARDX
  • APLS
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-08-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 11.22% -1.57%
The percentage of cash held in the portfolio is: 88.78%
New Assets Added
None
Assets Removed
Asset Action Perf %
RCM Sell All 7.37%
Assets Rebalanced
None
2024-08-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 9.31% 7.37%
CYH Community Health Systems, Inc. Buy 10.88% -4.91%
The percentage of cash held in the portfolio is: 79.81%
New Assets Added
None
Assets Removed
Asset Action Perf %
OPK Sell All 13.64%
Assets Rebalanced
None
2024-08-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 8.58% -3.03%
RCM R1 RCM Inc. Buy 9.46% 7.14%
CYH Community Health Systems, Inc. Buy 10.76% -7.66%
The percentage of cash held in the portfolio is: 71.2%
New Assets Added
None
Assets Removed
Asset Action Perf %
RMD Sell All 1.39%
Assets Rebalanced
None
2024-08-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 8.72% -0.76%
RCM R1 RCM Inc. Buy 9.38% 7.06%
CYH Community Health Systems, Inc. Buy 10.96% -5.3%
RMD ResMed Inc. Buy 10.77% 3.67%
The percentage of cash held in the portfolio is: 60.17%
New Assets Added
None
Assets Removed
Asset Action Perf %
PDSB Sell All -10.51%
Assets Rebalanced
None
2024-08-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 7.94% -8.52%
OPK OPKO Health, Inc. Buy 8.87% 2.27%
RCM R1 RCM Inc. Buy 9.33% 7.83%
CYH Community Health Systems, Inc. Buy 11.2% -1.96%
RMD ResMed Inc. Buy 11.02% 7.5%
The percentage of cash held in the portfolio is: 51.64%
New Assets Added
None
Assets Removed
Asset Action Perf %
HQY Sell All -11.82%
HCSG Sell All -6.49%
Assets Rebalanced
None
2024-08-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 7.88% -8.24%
OPK OPKO Health, Inc. Buy 8.98% 4.55%
RCM R1 RCM Inc. Buy 9.28% 8.44%
CYH Community Health Systems, Inc. Buy 11.13% -1.57%
HQY HealthEquity, Inc. Buy 10.87% -3.84%
HCSG Healthcare Services Group, Inc. Buy 9.19% -3.72%
RMD ResMed Inc. Buy 10.47% 3.13%
The percentage of cash held in the portfolio is: 32.21%
New Assets Added
None
Assets Removed
Asset Action Perf %
FATE Sell All -12.39%
Assets Rebalanced
None
2024-08-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 8.53% 1.14%
OPK OPKO Health, Inc. Buy 9.08% 7.58%
RCM R1 RCM Inc. Buy 8.32% -1.15%
FATE Fate Therapeutics, Inc. Buy 8.16% -4.31%
CYH Community Health Systems, Inc. Buy 11.48% 3.34%
HQY HealthEquity, Inc. Buy 10.77% -3.09%
HCSG Healthcare Services Group, Inc. Buy 9.27% -1.12%
RMD ResMed Inc. Buy 10.22% 2.5%
The percentage of cash held in the portfolio is: 24.18%
New Assets Added
None
Assets Removed
Asset Action Perf %
VRDN Sell All 27.55%
Assets Rebalanced
None
2024-07-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 12.24% 26.42%
PDSB PDS Biotechnology Corporation Buy 8.38% -1.7%
OPK OPKO Health, Inc. Buy 9.23% 8.33%
RCM R1 RCM Inc. Buy 8.41% -1%
FATE Fate Therapeutics, Inc. Buy 7.93% -7.9%
CYH Community Health Systems, Inc. Buy 11.37% 1.38%
HQY HealthEquity, Inc. Buy 10.86% -3.16%
HCSG Healthcare Services Group, Inc. Buy 9.43% -0.43%
RMD ResMed Inc. Buy 10.07% 0%
The percentage of cash held in the portfolio is: 12.07%
New Assets Added
  • RMD
Assets Removed
Asset Action Perf %
SMTI Sell All -8.69%
CLDX Sell All -12.36%
Assets Rebalanced
None
2024-07-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 12.28% 30.89%
PDSB PDS Biotechnology Corporation Buy 8.97% 8.52%
OPK OPKO Health, Inc. Buy 8.95% 8.33%
RCM R1 RCM Inc. Buy 8.02% -2.61%
FATE Fate Therapeutics, Inc. Buy 8.11% -2.87%
CLDX Celldex Therapeutics, Inc. Buy 10.42% -4.26%
SMTI Sanara MedTech Inc. Buy 10.29% -5.45%
CYH Community Health Systems, Inc. Buy 11.07% 1.77%
HQY HealthEquity, Inc. Buy 10.7% -1.69%
HCSG Healthcare Services Group, Inc. Buy 9.18% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • HCSG
Assets Removed
Asset Action Perf %
PTGX Sell All -7.35%
Assets Rebalanced
None
2024-07-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 11.63% 26.12%
PDSB PDS Biotechnology Corporation Buy 8.95% 10.23%
OPK OPKO Health, Inc. Buy 9.1% 12.12%
RCM R1 RCM Inc. Buy 8.08% -0.19%
FATE Fate Therapeutics, Inc. Buy 8.01% -2.33%
PTGX Protagonist Therapeutics, Inc. Buy 9.32% -3.84%
CLDX Celldex Therapeutics, Inc. Buy 10.86% 1.6%
SMTI Sanara MedTech Inc. Buy 10.69% 0%
CYH Community Health Systems, Inc. Buy 10.69% 0%
HQY HealthEquity, Inc. Buy 10.69% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • SMTI
  • CYH
  • HQY
Assets Removed
None
Assets Rebalanced
None
2024-07-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 11.45% 23.69%
PDSB PDS Biotechnology Corporation Buy 9.12% 11.93%
OPK OPKO Health, Inc. Buy 8.77% 7.58%
RCM R1 RCM Inc. Buy 8.06% -0.84%
FATE Fate Therapeutics, Inc. Buy 7.99% -3.05%
PTGX Protagonist Therapeutics, Inc. Buy 9.66% -0.76%
CLDX Celldex Therapeutics, Inc. Buy 10.74% 0%
The percentage of cash held in the portfolio is: 34.21%
New Assets Added
  • CLDX
Assets Removed
Asset Action Perf %
CYH Sell All 48.75%
Assets Rebalanced
None
2024-07-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 12.8% 35.31%
VRDN Viridian Therapeutics, Inc. Buy 11.33% 19.76%
PDSB PDS Biotechnology Corporation Buy 8.91% 6.96%
OPK OPKO Health, Inc. Buy 8.96% 7.58%
RCM R1 RCM Inc. Buy 8.38% 0.92%
FATE Fate Therapeutics, Inc. Buy 7.83% -7%
PTGX Protagonist Therapeutics, Inc. Buy 9.95% 0%
The percentage of cash held in the portfolio is: 31.85%
New Assets Added
  • PTGX
Assets Removed
Asset Action Perf %
ACAD Sell All 16.37%
EGRX Sell All 20.09%
Assets Rebalanced
None
2024-07-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 10.92% 14.55%
EGRX Eagle Pharmaceuticals, Inc. Buy 12.28% 28.79%
CYH Community Health Systems, Inc. Buy 11.77% 26.56%
VRDN Viridian Therapeutics, Inc. Buy 10.99% 18.17%
PDSB PDS Biotechnology Corporation Buy 9.84% 20.17%
OPK OPKO Health, Inc. Buy 8.94% 9.09%
RCM R1 RCM Inc. Buy 8.42% 3.07%
FATE Fate Therapeutics, Inc. Buy 8.28% 0%
The percentage of cash held in the portfolio is: 18.56%
New Assets Added
  • FATE
Assets Removed
None
Assets Rebalanced
None
2024-07-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 10.91% 11.78%
EGRX Eagle Pharmaceuticals, Inc. Buy 12.79% 31.03%
CYH Community Health Systems, Inc. Buy 11.21% 17.81%
VRDN Viridian Therapeutics, Inc. Buy 10.43% 9.54%
PDSB PDS Biotechnology Corporation Buy 9.22% 9.94%
OPK OPKO Health, Inc. Buy 9.46% 12.88%
RCM R1 RCM Inc. Buy 8.52% 2%
The percentage of cash held in the portfolio is: 27.46%
New Assets Added
None
Assets Removed
Asset Action Perf %
ALT Sell All -16.04%
Assets Rebalanced
None
2024-07-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 11.05% 13.35%
EGRX Eagle Pharmaceuticals, Inc. Buy 12.54% 28.57%
CYH Community Health Systems, Inc. Buy 11.2% 17.81%
VRDN Viridian Therapeutics, Inc. Buy 10.42% 9.54%
PDSB PDS Biotechnology Corporation Buy 9.18% 9.66%
ALT Altimmune, Inc. Buy 7.33% -12.43%
OPK OPKO Health, Inc. Buy 9.64% 15.15%
RCM R1 RCM Inc. Buy 8.23% -1.46%
The percentage of cash held in the portfolio is: 20.4%
New Assets Added
None
Assets Removed
Asset Action Perf %
RARE Sell All 7.35%
WST Sell All -5.09%
Assets Rebalanced
None
2024-07-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 10.92% 15.55%
EGRX Eagle Pharmaceuticals, Inc. Buy 12.61% 33.48%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.41% 10.14%
CYH Community Health Systems, Inc. Buy 11.35% 23.12%
VRDN Viridian Therapeutics, Inc. Buy 10.63% 15.37%
PDSB PDS Biotechnology Corporation Buy 9.25% 13.92%
ALT Altimmune, Inc. Buy 8.13% 0.13%
OPK OPKO Health, Inc. Buy 8.73% 7.58%
WST West Pharmaceutical Services, Inc. Buy 7.89% -1.88%
RCM R1 RCM Inc. Buy 8.09% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RCM
Assets Removed
Asset Action Perf %
BHVN Sell All 0.3%
Assets Rebalanced
None
2024-07-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 10.77% 11.15%
EGRX Eagle Pharmaceuticals, Inc. Buy 13.04% 34.6%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.67% 10.14%
CYH Community Health Systems, Inc. Buy 10.95% 15.94%
VRDN Viridian Therapeutics, Inc. Buy 9.26% -1.97%
PDSB PDS Biotechnology Corporation Buy 9.17% 10.23%
BHVN Biohaven Ltd. Buy 8.73% 4.89%
ALT Altimmune, Inc. Buy 8.54% 2.67%
OPK OPKO Health, Inc. Buy 8.63% 3.79%
WST West Pharmaceutical Services, Inc. Buy 8.24% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • WST
Assets Removed
None
Assets Rebalanced
None
2024-07-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 10.87% 7.75%
EGRX Eagle Pharmaceuticals, Inc. Buy 13.61% 34.82%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.76% 6.55%
CYH Community Health Systems, Inc. Buy 10.27% 4.37%
VRDN Viridian Therapeutics, Inc. Buy 9.14% -7.12%
PDSB PDS Biotechnology Corporation Buy 8.67% 0%
BHVN Biohaven Ltd. Buy 8.67% 0%
ALT Altimmune, Inc. Buy 8.67% 0%
OPK OPKO Health, Inc. Buy 8.67% 0%
The percentage of cash held in the portfolio is: 10.67%
New Assets Added
  • PDSB
  • BHVN
  • ALT
  • OPK
Assets Removed
None
Assets Rebalanced
None
2024-07-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 10.89% 7.87%
EGRX Eagle Pharmaceuticals, Inc. Buy 13.67% 35.49%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.7% 6.02%
CYH Community Health Systems, Inc. Buy 10.21% 3.75%
VRDN Viridian Therapeutics, Inc. Buy 9.2% -6.59%
The percentage of cash held in the portfolio is: 45.34%
New Assets Added
None
Assets Removed
Asset Action Perf %
NVRO Sell All -11.61%
Assets Rebalanced
None
2024-07-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 10.09% -1.83%
EGRX Eagle Pharmaceuticals, Inc. Buy 12.62% 22.77%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.37% 0.9%
CYH Community Health Systems, Inc. Buy 10.55% 5.31%
NVRO Nevro Corp. Buy 9.76% -2.67%
VRDN Viridian Therapeutics, Inc. Buy 9.3% -7.27%
The percentage of cash held in the portfolio is: 37.31%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Sell All 1.87%
Assets Rebalanced
None
2024-07-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 10.23% -0.25%
EGRX Eagle Pharmaceuticals, Inc. Buy 11.98% 16.74%
STAA STAAR Surgical Company Buy 10.8% 5.2%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.55% 2.79%
CYH Community Health Systems, Inc. Buy 10.72% 7.19%
NVRO Nevro Corp. Buy 9.71% -3.02%
VRDN Viridian Therapeutics, Inc. Buy 9.21% -7.95%
The percentage of cash held in the portfolio is: 26.8%
New Assets Added
None
Assets Removed
Asset Action Perf %
CHRS Sell All -19.65%
MNKD Sell All -7.37%
ARDX Sell All -28.74%
Assets Rebalanced
None
2024-07-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.71% 1.01%
MNKD MannKind Corporation Buy 9.01% -6.26%
EGRX Eagle Pharmaceuticals, Inc. Buy 11.86% 23.44%
STAA STAAR Surgical Company Buy 10.77% 12.05%
RARE Ultragenyx Pharmaceutical Inc. Buy 9.92% 3.19%
CYH Community Health Systems, Inc. Buy 9.72% 3.75%
ARDX Ardelyx, Inc. Buy 9.56% 2.16%
CHRS Coherus BioSciences, Inc. Buy 8.71% -6.94%
NVRO Nevro Corp. Buy 9.37% 0%
VRDN Viridian Therapeutics, Inc. Buy 9.37% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NVRO
  • VRDN
Assets Removed
None
Assets Rebalanced
None
2024-07-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.72% 2.33%
MNKD MannKind Corporation Buy 9.14% -3.87%
EGRX Eagle Pharmaceuticals, Inc. Buy 11.88% 25%
STAA STAAR Surgical Company Buy 10.69% 12.5%
RARE Ultragenyx Pharmaceutical Inc. Buy 9.8% 3.14%
CYH Community Health Systems, Inc. Buy 9.73% 5%
ARDX Ardelyx, Inc. Buy 9.26% 0%
CHRS Coherus BioSciences, Inc. Buy 9.26% 0%
The percentage of cash held in the portfolio is: 20.52%
New Assets Added
  • ARDX
  • CHRS
Assets Removed
None
Assets Rebalanced
None
2024-06-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.96% 3.09%
MNKD MannKind Corporation Buy 9.41% -2.58%
EGRX Eagle Pharmaceuticals, Inc. Buy 10.82% 12.05%
STAA STAAR Surgical Company Buy 10.68% 10.52%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.04% 3.94%
CYH Community Health Systems, Inc. Buy 9.42% 0%
The percentage of cash held in the portfolio is: 39.67%
New Assets Added
  • CYH
Assets Removed
None
Assets Rebalanced
None
2024-06-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.56% -2.39%
MNKD MannKind Corporation Buy 9.37% -4.42%
EGRX Eagle Pharmaceuticals, Inc. Buy 10.76% 9.82%
STAA STAAR Surgical Company Buy 10.54% 7.54%
RARE Ultragenyx Pharmaceutical Inc. Buy 9.97% 1.71%
The percentage of cash held in the portfolio is: 49.8%
New Assets Added
None
Assets Removed
Asset Action Perf %
FGEN Sell All -12.08%
Assets Rebalanced
None
2024-06-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.69% -1.76%
MNKD MannKind Corporation Buy 9.51% -3.5%
FGEN FibroGen, Inc. Buy 9.61% -2.5%
EGRX Eagle Pharmaceuticals, Inc. Buy 10.01% 1.56%
STAA STAAR Surgical Company Buy 9.86% 0%
RARE Ultragenyx Pharmaceutical Inc. Buy 9.86% 0%
The percentage of cash held in the portfolio is: 41.45%
New Assets Added
  • STAA
  • RARE
Assets Removed
None
Assets Rebalanced
None
2024-06-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.8% 0%
MNKD MannKind Corporation Buy 9.8% 0%
FGEN FibroGen, Inc. Buy 9.8% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 60.8%
New Assets Added
  • ACAD
  • MNKD
  • FGEN
  • EGRX
Assets Removed
None
Assets Rebalanced
None
2024-06-05 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
OMCL Sell All 1.76%
Assets Rebalanced
None
2024-06-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
OMCL Omnicell, Inc. Buy 11.95% 8.16%
The percentage of cash held in the portfolio is: 88.05%
New Assets Added
None
Assets Removed
Asset Action Perf %
INGN Sell All 17.73%
Assets Rebalanced
None
2024-05-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
INGN Inogen, Inc. Buy 10.78% 14.89%
OMCL Omnicell, Inc. Buy 11.72% 5.58%
The percentage of cash held in the portfolio is: 77.49%
New Assets Added
None
Assets Removed
Asset Action Perf %
SGMO Sell All 5.56%
Assets Rebalanced
None
2024-05-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
INGN Inogen, Inc. Buy 11.52% 24.96%
SGMO Sangamo Therapeutics, Inc. Buy 10.25% 11.11%
OMCL Omnicell, Inc. Buy 11.82% 8.3%
The percentage of cash held in the portfolio is: 66.41%
New Assets Added
None
Assets Removed
Asset Action Perf %
CARA Sell All -11.24%
SENS Sell All -8.83%
Assets Rebalanced
None
2024-05-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
CARA Cara Therapeutics, Inc. Buy 9.35% -2.91%
SENS Senseonics Holdings, Inc. Buy 8.89% -7.8%
INGN Inogen, Inc. Buy 10.77% 17.02%
SGMO Sangamo Therapeutics, Inc. Buy 10.57% 14.81%
OMCL Omnicell, Inc. Buy 11.46% 5.21%
The percentage of cash held in the portfolio is: 48.96%
New Assets Added
None
Assets Removed
Asset Action Perf %
VCYT Sell All -7.38%
Assets Rebalanced
None
2024-05-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
CARA Cara Therapeutics, Inc. Buy 9.58% 1.85%
SENS Senseonics Holdings, Inc. Buy 9.2% -2.26%
INGN Inogen, Inc. Buy 11.02% 22.55%
SGMO Sangamo Therapeutics, Inc. Buy 10.66% 18.52%
OMCL Omnicell, Inc. Buy 11.39% 7%
VCYT Veracyte, Inc. Buy 8.69% -3.91%
The percentage of cash held in the portfolio is: 39.45%
New Assets Added
None
Assets Removed
Asset Action Perf %
PODD Sell All -2.32%
ACRS Sell All -8.73%
Assets Rebalanced
None
2024-05-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
CARA Cara Therapeutics, Inc. Buy 9.39% -0.79%
SENS Senseonics Holdings, Inc. Buy 9.12% -3.7%
INGN Inogen, Inc. Buy 11.24% 24.26%
ACRS Aclaris Therapeutics, Inc. Buy 8.54% -5.56%
SGMO Sangamo Therapeutics, Inc. Buy 10.22% 12.96%
OMCL Omnicell, Inc. Buy 10.92% 1.99%
VCYT Veracyte, Inc. Buy 9.02% -0.89%
PODD Insulet Corporation Buy 8.2% -0.67%
The percentage of cash held in the portfolio is: 23.35%
New Assets Added
None
Assets Removed
Asset Action Perf %
PTCT Sell All 40.43%
Assets Rebalanced
None
2024-05-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 11.08% 15.84%
CARA Cara Therapeutics, Inc. Buy 9.48% -0.79%
SENS Senseonics Holdings, Inc. Buy 9.52% -0.41%
INGN Inogen, Inc. Buy 11.44% 25.25%
ACRS Aclaris Therapeutics, Inc. Buy 8.63% -5.56%
SGMO Sangamo Therapeutics, Inc. Buy 11% 20.37%
OMCL Omnicell, Inc. Buy 10.92% 1.03%
VCYT Veracyte, Inc. Buy 9.35% 1.69%
PODD Insulet Corporation Buy 8.43% 1.02%
The percentage of cash held in the portfolio is: 10.16%
New Assets Added
None
Assets Removed
Asset Action Perf %
IBRX Sell All -14.91%
Assets Rebalanced
None
2024-05-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 11.25% 19.11%
IBRX ImmunityBio, Inc. Buy 8.14% -13.79%
CARA Cara Therapeutics, Inc. Buy 10.05% 6.48%
SENS Senseonics Holdings, Inc. Buy 9.54% 1.03%
INGN Inogen, Inc. Buy 11.46% 26.95%
ACRS Aclaris Therapeutics, Inc. Buy 8.45% -6.35%
SGMO Sangamo Therapeutics, Inc. Buy 10.2% 12.96%
OMCL Omnicell, Inc. Buy 11.22% 5.08%
VCYT Veracyte, Inc. Buy 9.44% 4%
PODD Insulet Corporation Buy 8.24% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • PODD
Assets Removed
Asset Action Perf %
MD Sell All -8.68%
Assets Rebalanced
None
2024-05-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 10.75% 10.96%
IBRX ImmunityBio, Inc. Buy 9.3% -4%
CARA Cara Therapeutics, Inc. Buy 9.61% -0.79%
SENS Senseonics Holdings, Inc. Buy 8.84% -8.83%
INGN Inogen, Inc. Buy 11.58% 25.04%
ACRS Aclaris Therapeutics, Inc. Buy 8.67% -6.35%
SGMO Sangamo Therapeutics, Inc. Buy 9.43% 1.85%
OMCL Omnicell, Inc. Buy 11.2% 2.22%
MD Pediatrix Medical Group, Inc. Buy 9.31% 0%
VCYT Veracyte, Inc. Buy 9.31% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MD
  • VCYT
Assets Removed
None
Assets Rebalanced
None
2024-05-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 11.05% 12.88%
IBRX ImmunityBio, Inc. Buy 8.84% -9.68%
CARA Cara Therapeutics, Inc. Buy 9.26% -5.29%
SENS Senseonics Holdings, Inc. Buy 9.37% -4.31%
INGN Inogen, Inc. Buy 11.22% 20%
ACRS Aclaris Therapeutics, Inc. Buy 8.68% -7.14%
SGMO Sangamo Therapeutics, Inc. Buy 9.7% 3.7%
OMCL Omnicell, Inc. Buy 11.06% -0.03%
The percentage of cash held in the portfolio is: 20.83%
New Assets Added
None
Assets Removed
Asset Action Perf %
IOVA Sell All -12.24%
Assets Rebalanced
None
2024-05-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 10.39% 8.68%
IBRX ImmunityBio, Inc. Buy 8.57% -10.34%
CARA Cara Therapeutics, Inc. Buy 9.61% 0.53%
SENS Senseonics Holdings, Inc. Buy 9.45% -1.23%
INGN Inogen, Inc. Buy 11.26% 23.26%
ACRS Aclaris Therapeutics, Inc. Buy 8.88% -2.78%
IOVA Iovance Biotherapeutics, Inc. Buy 9.83% 7.6%
SGMO Sangamo Therapeutics, Inc. Buy 8.8% -3.7%
OMCL Omnicell, Inc. Buy 10.86% 0.4%
The percentage of cash held in the portfolio is: 12.34%
New Assets Added
None
Assets Removed
Asset Action Perf %
CDMO Sell All 7.67%
Assets Rebalanced
None
2024-05-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 10.8% 15.54%
IBRX ImmunityBio, Inc. Buy 9.51% 1.78%
CDMO Avid Bioservices, Inc. Buy 10.2% 9.13%
CARA Cara Therapeutics, Inc. Buy 9.62% 2.94%
SENS Senseonics Holdings, Inc. Buy 9.69% 3.68%
INGN Inogen, Inc. Buy 9.06% 1.42%
ACRS Aclaris Therapeutics, Inc. Buy 9.64% 7.94%
IOVA Iovance Biotherapeutics, Inc. Buy 9.74% 9.04%
SGMO Sangamo Therapeutics, Inc. Buy 9.19% 2.93%
OMCL Omnicell, Inc. Buy 10.57% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • OMCL
Assets Removed
Asset Action Perf %
SMMT Sell All 13.73%
Assets Rebalanced
None
2024-05-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 11.54% 19.57%
SMMT Summit Therapeutics Inc. Buy 11.75% 21.76%
IBRX ImmunityBio, Inc. Buy 9.17% -5.01%
CDMO Avid Bioservices, Inc. Buy 9.79% 1.46%
CARA Cara Therapeutics, Inc. Buy 9.69% 0.4%
SENS Senseonics Holdings, Inc. Buy 9.18% -4.93%
INGN Inogen, Inc. Buy 9.22% 0%
ACRS Aclaris Therapeutics, Inc. Buy 9.22% 0%
IOVA Iovance Biotherapeutics, Inc. Buy 9.22% 0%
SGMO Sangamo Therapeutics, Inc. Buy 9.22% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • INGN
  • ACRS
  • IOVA
  • SGMO
Assets Removed
Asset Action Perf %
OPK Sell All -3.05%
Assets Rebalanced
None
2024-05-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 7.93% -6.87%
PTCT PTC Therapeutics, Inc. Buy 11.22% 12.53%
SMMT Summit Therapeutics Inc. Buy 10.15% 1.81%
IBRX ImmunityBio, Inc. Buy 8.86% -11.12%
CDMO Avid Bioservices, Inc. Buy 10.06% 0.93%
CARA Cara Therapeutics, Inc. Buy 9.91% -0.53%
SENS Senseonics Holdings, Inc. Buy 9.97% 0%
The percentage of cash held in the portfolio is: 31.91%
New Assets Added
  • SENS
Assets Removed
None
Assets Rebalanced
None
2024-04-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 7.97% -5.34%
PTCT PTC Therapeutics, Inc. Buy 11.1% 12.5%
SMMT Summit Therapeutics Inc. Buy 9.91% 0.52%
IBRX ImmunityBio, Inc. Buy 9.86% 0%
CDMO Avid Bioservices, Inc. Buy 9.86% 0%
CARA Cara Therapeutics, Inc. Buy 9.86% 0%
The percentage of cash held in the portfolio is: 41.44%
New Assets Added
  • IBRX
  • CDMO
  • CARA
Assets Removed
None
Assets Rebalanced
None
2024-04-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 8.2% -3.82%
PTCT PTC Therapeutics, Inc. Buy 9.98% 0%
SMMT Summit Therapeutics Inc. Buy 9.98% 0%
The percentage of cash held in the portfolio is: 71.85%
New Assets Added
  • PTCT
  • SMMT
Assets Removed
Asset Action Perf %
ANGO Sell All 1.93%
KIDS Sell All 4.45%
ACRS Sell All -4.76%
Assets Rebalanced
None
2024-04-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 10.1% 10.7%
KIDS OrthoPediatrics Corp. Buy 9.59% 5.11%
ACRS Aclaris Therapeutics, Inc. Buy 8.76% -3.97%
OPK OPKO Health, Inc. Buy 7.94% -6.11%
The percentage of cash held in the portfolio is: 63.61%
New Assets Added
None
Assets Removed
Asset Action Perf %
TNDM Sell All -9.75%
Assets Rebalanced
None
2024-04-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 11.11% 23.33%
TNDM Tandem Diabetes Care, Inc. Buy 8.59% -4.65%
KIDS OrthoPediatrics Corp. Buy 8.54% -5.18%
ACRS Aclaris Therapeutics, Inc. Buy 8.5% -5.56%
OPK OPKO Health, Inc. Buy 8.6% 3.05%
The percentage of cash held in the portfolio is: 54.66%
New Assets Added
None
Assets Removed
Asset Action Perf %
BAX Sell All -0.86%
Assets Rebalanced
None
2024-04-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
BAX Baxter International Inc. Buy 13.55% -0.19%
ANGO AngioDynamics, Inc. Buy 9.91% 8.6%
TNDM Tandem Diabetes Care, Inc. Buy 8.66% -5.1%
KIDS OrthoPediatrics Corp. Buy 8.4% -7.9%
ACRS Aclaris Therapeutics, Inc. Buy 8.83% -3.17%
OPK OPKO Health, Inc. Buy 8.72% 3.05%
The percentage of cash held in the portfolio is: 41.92%
New Assets Added
None
Assets Removed
Asset Action Perf %
OMCL Sell All -0.14%
VCYT Sell All -5.57%
THC Sell All 9.07%
Assets Rebalanced
None
2024-04-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 9.28% 10.71%
BAX Baxter International Inc. Buy 13.58% 1.3%
OMCL Omnicell, Inc. Buy 13.81% 3.02%
ANGO AngioDynamics, Inc. Buy 9.22% 2.28%
TNDM Tandem Diabetes Care, Inc. Buy 8.64% -4.11%
KIDS OrthoPediatrics Corp. Buy 8.77% -2.69%
ACRS Aclaris Therapeutics, Inc. Buy 9.01% 0%
VCYT Veracyte, Inc. Buy 8.98% -0.37%
OPK OPKO Health, Inc. Buy 8.35% 0%
The percentage of cash held in the portfolio is: 10.35%
New Assets Added
  • OPK
Assets Removed
Asset Action Perf %
OFIX Sell All -3.17%
ATRI Sell All -11.81%
Assets Rebalanced
None
2024-03-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 9.14% 11.48%
BAX Baxter International Inc. Buy 13.03% -0.58%
OMCL Omnicell, Inc. Buy 13.79% 5.18%
ANGO AngioDynamics, Inc. Buy 9.07% 2.98%
TNDM Tandem Diabetes Care, Inc. Buy 8.84% 0.31%
KIDS OrthoPediatrics Corp. Buy 8.87% 0.66%
ACRS Aclaris Therapeutics, Inc. Buy 8.67% -1.59%
VCYT Veracyte, Inc. Buy 8.99% 2.03%
ATRI Atrion Corporation Buy 8.8% 0%
OFIX Orthofix Medical Inc. Buy 8.8% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ATRI
  • OFIX
Assets Removed
None
Assets Rebalanced
None
2024-03-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 9.16% 11.22%
BAX Baxter International Inc. Buy 13.07% -0.7%
OMCL Omnicell, Inc. Buy 13.85% 5.22%
ANGO AngioDynamics, Inc. Buy 8.85% 0%
TNDM Tandem Diabetes Care, Inc. Buy 8.85% 0%
KIDS OrthoPediatrics Corp. Buy 8.85% 0%
ACRS Aclaris Therapeutics, Inc. Buy 8.85% 0%
VCYT Veracyte, Inc. Buy 8.85% 0%
The percentage of cash held in the portfolio is: 19.69%
New Assets Added
  • ANGO
  • TNDM
  • KIDS
  • ACRS
  • VCYT
Assets Removed
None
Assets Rebalanced
None
2024-03-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 9.06% 8.8%
BAX Baxter International Inc. Buy 12.95% -2.7%
OMCL Omnicell, Inc. Buy 13.38% 0.5%
The percentage of cash held in the portfolio is: 64.62%
New Assets Added
None
Assets Removed
Asset Action Perf %
QTRX Sell All -9.55%
Assets Rebalanced
None
2024-03-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 8.88% 6.46%
QTRX Quanterix Corporation Buy 6.73% -5.31%
BAX Baxter International Inc. Buy 12.89% -3.37%
OMCL Omnicell, Inc. Buy 13.18% -1.15%
The percentage of cash held in the portfolio is: 58.32%
New Assets Added
None
Assets Removed
Asset Action Perf %
ABUS Sell All -5.93%
Assets Rebalanced
None
2024-03-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 8.71% 4.78%
QTRX Quanterix Corporation Buy 6.7% -5.42%
BAX Baxter International Inc. Buy 12.87% -3.21%
OMCL Omnicell, Inc. Buy 13.25% -0.36%
ABUS Arbutus Biopharma Corporation Buy 10.56% -2.96%
The percentage of cash held in the portfolio is: 47.91%
New Assets Added
None
Assets Removed
Asset Action Perf %
BRKR Sell All 15.05%
RCM Sell All 21.04%
Assets Rebalanced
None
2024-03-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
BRKR Bruker Corporation Buy 11.3% 14.72%
RCM R1 RCM Inc. Buy 11.52% 22.38%
THC Tenet Healthcare Corporation Buy 8.8% 6.1%
QTRX Quanterix Corporation Buy 6.64% -6.02%
BAX Baxter International Inc. Buy 12.97% -2.26%
OMCL Omnicell, Inc. Buy 13.17% -0.72%
ABUS Arbutus Biopharma Corporation Buy 10.5% -3.33%
The percentage of cash held in the portfolio is: 25.09%
New Assets Added
None
Assets Removed
Asset Action Perf %
MRSN Sell All -15.74%
Assets Rebalanced
None
2024-03-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
BRKR Bruker Corporation Buy 11.16% 15.83%
RCM R1 RCM Inc. Buy 11.57% 25.69%
THC Tenet Healthcare Corporation Buy 8.61% 6.01%
MRSN Mersana Therapeutics, Inc. Buy 7.71% -5.05%
QTRX Quanterix Corporation Buy 6.61% -4.49%
BAX Baxter International Inc. Buy 12.95% -0.23%
OMCL Omnicell, Inc. Buy 13.12% 1.04%
ABUS Arbutus Biopharma Corporation Buy 10.59% -0.37%
The percentage of cash held in the portfolio is: 17.7%
New Assets Added
None
Assets Removed
Asset Action Perf %
ENTA Sell All -5.28%
Assets Rebalanced
None
2024-03-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
BRKR Bruker Corporation Buy 10.88% 13.88%
RCM R1 RCM Inc. Buy 11.35% 24.26%
THC Tenet Healthcare Corporation Buy 8.43% 4.66%
MRSN Mersana Therapeutics, Inc. Buy 7.84% -2.69%
ENTA Enanta Pharmaceuticals, Inc. Buy 8.08% 0.33%
QTRX Quanterix Corporation Buy 6.49% -5.45%
BAX Baxter International Inc. Buy 13.11% 1.81%
OMCL Omnicell, Inc. Buy 13.23% 2.73%
ABUS Arbutus Biopharma Corporation Buy 10.66% 1.11%
The percentage of cash held in the portfolio is: 9.93%
New Assets Added
None
Assets Removed
Asset Action Perf %
NUTX Sell All -17.21%
Assets Rebalanced
None
2024-03-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
NUTX Nutex Health Inc. Buy 8.23% -13.11%
BRKR Bruker Corporation Buy 10.91% 15.17%
RCM R1 RCM Inc. Buy 11.5% 27.04%
THC Tenet Healthcare Corporation Buy 8.31% 4.1%
MRSN Mersana Therapeutics, Inc. Buy 7.86% -1.52%
ENTA Enanta Pharmaceuticals, Inc. Buy 8.17% 2.41%
QTRX Quanterix Corporation Buy 6.79% -0.07%
BAX Baxter International Inc. Buy 12.91% 1.16%
OMCL Omnicell, Inc. Buy 12.88% 0.97%
ABUS Arbutus Biopharma Corporation Buy 10.45% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ABUS
Assets Removed
Asset Action Perf %
ATRI Sell All 18.86%
Assets Rebalanced
None
2024-03-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATRI Atrion Corporation Buy 10.1% 13.11%
NUTX Nutex Health Inc. Buy 8.41% -12.3%
BRKR Bruker Corporation Buy 10.85% 13.09%
RCM R1 RCM Inc. Buy 11.44% 24.71%
THC Tenet Healthcare Corporation Buy 8.35% 3.23%
MRSN Mersana Therapeutics, Inc. Buy 7.81% -3.37%
ENTA Enanta Pharmaceuticals, Inc. Buy 8.25% 2.02%
QTRX Quanterix Corporation Buy 6.94% 0.75%
BAX Baxter International Inc. Buy 12.93% 0%
OMCL Omnicell, Inc. Buy 12.93% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • BAX
  • OMCL
Assets Removed
None
Assets Rebalanced
None
2024-03-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATRI Atrion Corporation Buy 10.52% 17.92%
NUTX Nutex Health Inc. Buy 8.49% -11.48%
BRKR Bruker Corporation Buy 10.8% 12.64%
RCM R1 RCM Inc. Buy 11.46% 25.07%
THC Tenet Healthcare Corporation Buy 8.19% 1.35%
MRSN Mersana Therapeutics, Inc. Buy 7.85% -2.86%
ENTA Enanta Pharmaceuticals, Inc. Buy 7.93% -1.89%
QTRX Quanterix Corporation Buy 6.92% 0.5%
The percentage of cash held in the portfolio is: 27.84%
New Assets Added
None
Assets Removed
Asset Action Perf %
NTLA Sell All 19.61%
RGNX Sell All 68.91%
Assets Rebalanced
None
2024-03-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 11.7% 28.07%
ATRI Atrion Corporation Buy 10.08% 11.54%
RGNX REGENXBIO Inc. Buy 13.24% 46.6%
NUTX Nutex Health Inc. Buy 9.07% -6.56%
BRKR Bruker Corporation Buy 10.92% 12.49%
RCM R1 RCM Inc. Buy 11.62% 25.25%
THC Tenet Healthcare Corporation Buy 8.13% -0.63%
MRSN Mersana Therapeutics, Inc. Buy 7.92% -3.2%
ENTA Enanta Pharmaceuticals, Inc. Buy 8.34% 1.95%
QTRX Quanterix Corporation Buy 6.97% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • QTRX
Assets Removed
Asset Action Perf %
RVNC Sell All -14.99%
Assets Rebalanced
None
2024-03-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 11.78% 29.14%
ATRI Atrion Corporation Buy 9.29% 3.03%
RGNX REGENXBIO Inc. Buy 13.12% 45.44%
NUTX Nutex Health Inc. Buy 8.98% -7.38%
BRKR Bruker Corporation Buy 10.7% 10.34%
RCM R1 RCM Inc. Buy 11.62% 25.34%
RVNC Revance Therapeutics, Inc. Buy 8% -2.24%
THC Tenet Healthcare Corporation Buy 8.17% 0%
MRSN Mersana Therapeutics, Inc. Buy 8.17% 0%
ENTA Enanta Pharmaceuticals, Inc. Buy 8.17% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • THC
  • MRSN
  • ENTA
Assets Removed
None
Assets Rebalanced
None
2024-03-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 11.86% 27.01%
ATRI Atrion Corporation Buy 9.75% 5.65%
RGNX REGENXBIO Inc. Buy 11.05% 19.7%
NUTX Nutex Health Inc. Buy 9.19% -7.38%
BRKR Bruker Corporation Buy 10.73% 8.11%
RCM R1 RCM Inc. Buy 11.93% 25.78%
RVNC Revance Therapeutics, Inc. Buy 8.37% 0%
The percentage of cash held in the portfolio is: 27.12%
New Assets Added
  • RVNC
Assets Removed
Asset Action Perf %
CARA Sell All 32.4%
NVAX Sell All 14.88%
VRDN Sell All -7.24%
Assets Rebalanced
None
2024-02-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 11.91% 29.7%
ATRI Atrion Corporation Buy 9.46% 4.21%
RGNX REGENXBIO Inc. Buy 12.4% 36.58%
NUTX Nutex Health Inc. Buy 8.96% -8.2%
BRKR Bruker Corporation Buy 10.54% 8.03%
RCM R1 RCM Inc. Buy 12.02% 28.83%
NVAX Novavax, Inc. Buy 9.57% 2.56%
CARA Cara Therapeutics, Inc. Buy 10.8% 38.63%
VRDN Viridian Therapeutics, Inc. Buy 6.17% 0%
The percentage of cash held in the portfolio is: 8.17%
New Assets Added
  • VRDN
Assets Removed
Asset Action Perf %
CUTR Sell All -32.07%
INGN Sell All -38.03%
Assets Rebalanced
None
2024-02-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 10.27% 7.35%
ATRI Atrion Corporation Buy 9.66% 2.22%
RGNX REGENXBIO Inc. Buy 12.03% 27.25%
NUTX Nutex Health Inc. Buy 9.58% -5.74%
BRKR Bruker Corporation Buy 10.3% 1.31%
CUTR Cutera, Inc. Buy 10.27% 1.03%
RCM R1 RCM Inc. Buy 9.37% -3.58%
INGN Inogen, Inc. Buy 9.08% -6.5%
NVAX Novavax, Inc. Buy 9.33% -3.95%
CARA Cara Therapeutics, Inc. Buy 8.11% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • CARA
Assets Removed
Asset Action Perf %
MRSN Sell All -14.18%
Assets Rebalanced
None
2024-02-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 10.49% 12.57%
ATRI Atrion Corporation Buy 9.36% 1.57%
RGNX REGENXBIO Inc. Buy 11.67% 26.63%
MRSN Mersana Therapeutics, Inc. Buy 8.31% -9.22%
NUTX Nutex Health Inc. Buy 9.83% -0.82%
BRKR Bruker Corporation Buy 9.91% 0.06%
CUTR Cutera, Inc. Buy 10.01% 1.03%
RCM R1 RCM Inc. Buy 9.47% 0%
INGN Inogen, Inc. Buy 9.47% 0%
NVAX Novavax, Inc. Buy 9.47% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RCM
  • INGN
  • NVAX
Assets Removed
Asset Action Perf %
AGEN Sell All -7.14%
Assets Rebalanced
None
2024-02-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 10.23% 11.82%
ATRI Atrion Corporation Buy 8.72% -3.57%
AGEN Agenus Inc. Buy 11.99% 32.56%
RGNX REGENXBIO Inc. Buy 10.42% 15.24%
MRSN Mersana Therapeutics, Inc. Buy 8.05% -10.4%
NUTX Nutex Health Inc. Buy 9.72% 0%
BRKR Bruker Corporation Buy 9.72% 0%
CUTR Cutera, Inc. Buy 9.72% 0%
The percentage of cash held in the portfolio is: 21.44%
New Assets Added
  • NUTX
  • BRKR
  • CUTR
Assets Removed
Asset Action Perf %
LXRX Sell All 55.87%
Assets Rebalanced
None
2024-02-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Buy 13.21% 37.56%
NTLA Intellia Therapeutics, Inc. Buy 10.04% 4.59%
ATRI Atrion Corporation Buy 9.3% -2.04%
AGEN Agenus Inc. Buy 10.31% 8.57%
RGNX REGENXBIO Inc. Buy 10.45% 10.09%
MRSN Mersana Therapeutics, Inc. Buy 8.54% -9.46%
The percentage of cash held in the portfolio is: 38.15%
New Assets Added
None
Assets Removed
Asset Action Perf %
ARCT Sell All 2.7%
SAVA Sell All -6.26%
SMTI Sell All -9.09%
CLDX Sell All -6.72%
Assets Rebalanced
None
2024-02-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Buy 10.3% 7.98%
NTLA Intellia Therapeutics, Inc. Buy 10.36% 8.62%
ATRI Atrion Corporation Buy 9.97% 5.75%
ARCT Arcturus Therapeutics Holdings Inc. Buy 9.47% 0.42%
AGEN Agenus Inc. Buy 9.43% 0%
SMTI Sanara MedTech Inc. Buy 9.82% 4.06%
RGNX REGENXBIO Inc. Buy 10.55% 11.81%
CLDX Celldex Therapeutics, Inc. Buy 9.36% -0.77%
SAVA Cassava Sciences, Inc. Buy 9.38% -0.59%
MRSN Mersana Therapeutics, Inc. Buy 9.37% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MRSN
Assets Removed
None
Assets Rebalanced
None
2024-02-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Buy 9.93% 0.94%
NTLA Intellia Therapeutics, Inc. Buy 10.14% 3.08%
ATRI Atrion Corporation Buy 10.27% 5.59%
ARCT Arcturus Therapeutics Holdings Inc. Buy 9.61% -1.19%
AGEN Agenus Inc. Buy 9.44% -2.86%
SMTI Sanara MedTech Inc. Buy 9.72% 0%
RGNX REGENXBIO Inc. Buy 9.72% 0%
CLDX Celldex Therapeutics, Inc. Buy 9.72% 0%
SAVA Cassava Sciences, Inc. Buy 9.72% 0%
The percentage of cash held in the portfolio is: 11.72%
New Assets Added
  • SMTI
  • RGNX
  • CLDX
  • SAVA
Assets Removed
None
Assets Rebalanced
None
2024-02-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Buy 10.17% 3.76%
NTLA Intellia Therapeutics, Inc. Buy 10.3% 5.06%
ATRI Atrion Corporation Buy 9.69% 0%
ARCT Arcturus Therapeutics Holdings Inc. Buy 9.69% 0%
AGEN Agenus Inc. Buy 9.69% 0%
The percentage of cash held in the portfolio is: 50.46%
New Assets Added
  • ATRI
  • ARCT
  • AGEN
Assets Removed
None
Assets Rebalanced
None
2024-02-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Buy 9.57% -3.76%
NTLA Intellia Therapeutics, Inc. Buy 9.76% -1.78%
The percentage of cash held in the portfolio is: 80.67%
New Assets Added
None
Assets Removed
Asset Action Perf %
PTGX Sell All -8.8%
Assets Rebalanced
None
2024-02-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTGX Protagonist Therapeutics, Inc. Buy 9.17% -7.12%
LXRX Lexicon Pharmaceuticals, Inc. Buy 9.87% 0%
NTLA Intellia Therapeutics, Inc. Buy 9.87% 0%
The percentage of cash held in the portfolio is: 71.09%
New Assets Added
  • LXRX
  • NTLA
Assets Removed
None
Assets Rebalanced
None
2024-02-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTGX Protagonist Therapeutics, Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 90.2%
New Assets Added
  • PTGX
Assets Removed
None
Assets Rebalanced
None
2023-12-18 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
HCSG Sell All -1.67%
Assets Rebalanced
None
2023-12-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Buy 11.28% -0.59%
The percentage of cash held in the portfolio is: 88.72%
New Assets Added
None
Assets Removed
Asset Action Perf %
NVCR Sell All 6.02%
THC Sell All 31.73%
SGRY Sell All 17.23%
AMEH Sell All 8.26%
Assets Rebalanced
None
2023-12-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
NVCR NovoCure Limited Buy 8.76% 3.28%
THC Tenet Healthcare Corporation Buy 10.77% 27.01%
SGRY Surgery Partners, Inc. Buy 9.64% 13.65%
AMEH Apollo Medical Holdings, Inc. Buy 8.79% 3.72%
HCSG Healthcare Services Group, Inc. Buy 11.52% 0.29%
The percentage of cash held in the portfolio is: 50.53%
New Assets Added
None
Assets Removed
Asset Action Perf %
CBAY Sell All 26.67%
SENS Sell All 13.51%
Assets Rebalanced
None
2023-12-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
CBAY CymaBay Therapeutics, Inc. Buy 11.2% 29.05%
SENS Senseonics Holdings, Inc. Buy 9.82% 13.15%
NVCR NovoCure Limited Buy 8.72% 0.62%
THC Tenet Healthcare Corporation Buy 10.22% 17.93%
SGRY Surgery Partners, Inc. Buy 9.33% 7.62%
AMEH Apollo Medical Holdings, Inc. Buy 8.45% -2.46%
HCSG Healthcare Services Group, Inc. Buy 11.44% -2.65%
The percentage of cash held in the portfolio is: 30.82%
New Assets Added
None
Assets Removed
Asset Action Perf %
BMRN Sell All 11.05%
Assets Rebalanced
None
2023-12-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
BMRN BioMarin Pharmaceutical Inc. Buy 11.05% 8.11%
CBAY CymaBay Therapeutics, Inc. Buy 10.16% 16.83%
SENS Senseonics Holdings, Inc. Buy 10.01% 15.14%
NVCR NovoCure Limited Buy 8.48% -2.34%
THC Tenet Healthcare Corporation Buy 10.55% 21.47%
SGRY Surgery Partners, Inc. Buy 9.8% 12.82%
AMEH Apollo Medical Holdings, Inc. Buy 8.86% 1.99%
HCSG Healthcare Services Group, Inc. Buy 11.55% -1.86%
The percentage of cash held in the portfolio is: 19.53%
New Assets Added
None
Assets Removed
Asset Action Perf %
EW Sell All 7.1%
ISRG Sell All 13.43%
Assets Rebalanced
None
2023-11-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
EW Edwards Lifesciences Corporation Buy 8.88% 4.98%
ISRG Intuitive Surgical, Inc. Buy 8.9% 5.52%
BMRN BioMarin Pharmaceutical Inc. Buy 11% 1.84%
CBAY CymaBay Therapeutics, Inc. Buy 9.8% 6.7%
SENS Senseonics Holdings, Inc. Buy 10.03% 9.19%
NVCR NovoCure Limited Buy 9.09% -0.94%
THC Tenet Healthcare Corporation Buy 9.21% 0.33%
SGRY Surgery Partners, Inc. Buy 9.45% 2.98%
AMEH Apollo Medical Holdings, Inc. Buy 9.21% 0.41%
HCSG Healthcare Services Group, Inc. Buy 12.43% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • HCSG
Assets Removed
Asset Action Perf %
PODD Sell All 27.65%
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings